Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.40 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 2/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19968095 | 0.86 | PARP14 (0.48) | GPR3ALOX5SLC9A1PARP14MAPT | |
| SCHEMBL9525819 | 0.81 | CYP2A6 (0.48) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL17454809 | 0.81 | GPR3 (0.48) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL30705823 | 0.81 | CYP2A6 (0.48) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL25165131 | 0.78 | GPR3 (0.45) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL3052012 | 0.77 | GPR3 (0.48) | GPR3SLC9A1MAPTRAB9AMEN1 | |
| SCHEMBL15834692 | 0.74 | CYP2A6 (0.42) | GPR3SLC9A1MAPTRAB9AMEN1 | |
| SCHEMBL15497424 | 0.74 | GPR3 (0.68) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL1039859 | 0.74 | GPR3 (0.68) | GPR3ALOX5PARP14MAPTRAB9A | |
| SCHEMBL355686 | 0.74 | GPR3 (0.54) | GPR3ALOX5PARP14MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100221646-A1 | HOLOGRAPHIC RECORDING MEDIUM | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-09-02 | — | — | US | claimed |
| WO-2023063163-A1 | MIXED POWDER FOR ORGANIC ELECTROLUMINESCENT ELEMENT, PRODUCTION METHOD THEREFOR, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID MIXED POWDER, METHOD FOR SELECTING COMPOUND IN SAID MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION | 出光興産株式会社 | 2023-04-20 | — | — | WO | disclosed |
| EP-3248230-B1 | USE OF ORGANIC MOLECULES IN OPTOELECTRONIC COMPONENTS | CYNORA GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-20100221646-A1 | HOLOGRAPHIC RECORDING MEDIUM | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100221646-A1 | HOLOGRAPHIC RECORDING MEDIUM | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-09-02 | — | — | US | disclosed |
| US-7663301-B2 | for use as robust red organic phosphors | GENERAL ELECTRIC COMPANY (US) | 2010-02-16 | — | — | US | disclosed |
| WO-2006076247-A2 | PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060152149-A1 | Porphyrin compositions | GENERAL ELECTRIC COMPANY (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060152149-A1 | Porphyrin compositions | ACP1, MMS19, MVD | GPR3 3994/4885ALOX5 1190/4885SLC9A1 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.